Patents by Inventor LINGHUI WU

LINGHUI WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250067384
    Abstract: The present disclosure provides a display mounting support including a wall plate and at least one hanging assembly. The wall plate defines a hanging hook groove. The hanging assembly is hung into the hanging hook groove. Each hanging assembly includes a hanging hook member, a retractable mechanism and a display hanging member. The hanging hook member includes a hanging rod, a connecting rod and a hanging hook. The connecting rod is connected between the hanging rod and the hanging hook. The hanging hook includes a cantilever portion and a first concave structure. The retractable mechanism is connected between the hanging rod and the display hanging member. The display hanging member is configured to fix to a back of a display. The hanging hook of the hanging assembly is inserted into the hanging hook groove for hanging the display on the wall plate.
    Type: Application
    Filed: December 6, 2023
    Publication date: February 27, 2025
    Applicant: Xinadda (Hong Kong) Limited
    Inventors: Hao XU, Linghui WU
  • Patent number: 11466024
    Abstract: A bicyclic compound acting as a ROR? inhibitor. Provided are a compound of formula (I) or a pharmaceutically acceptable salt thereof, the compound having a structure as represented by formula (I-A) or formula (I-B). The provided compound of formula (I-A) or formula (I-B) or pharmaceutically acceptable salt thereof has good ROR? inhibitory activities, being expected to be used for treating diseases mediated by ROR? receptors in a mammal.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: October 11, 2022
    Assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Medshine Discovery Inc.
    Inventors: Kevin X Chen, Kai Zhou, Yanxin Yu, Boyu Hu, Linghui Wu, Xiaoyuan Chen, Jiangfeng Lin, Haomin Chen, Xiangjian Wang, Xiquan Zhang, Xin Tian, Hongjiang Xu
  • Patent number: 11117899
    Abstract: Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A2A receptor. The R1, R2, R3, ring A, ring B, n, and m are as defined in the specification.
    Type: Grant
    Filed: April 8, 2018
    Date of Patent: September 14, 2021
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Kevin X Chen, Yanxin Yu, Xinde Chen, Li Zhang, Zhaoguo Chen, Cheng Xie, Xiaofei Wang, Linghui Wu, Guoping Hu, Jian Li, Shuhui Chen
  • Patent number: 11066411
    Abstract: Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A2A receptor. The R1, R2, R3, ring A, ring B, n, and m are as defined in the specification.
    Type: Grant
    Filed: April 8, 2018
    Date of Patent: July 20, 2021
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Kevin X Chen, Yanxin Yu, Xinde Chen, Li Zhang, Zhaoguo Chen, Cheng Xie, Xiaofei Wang, Linghui Wu, Guoping Hu, Jian Li, Shuhui Chen
  • Patent number: 10858322
    Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: December 8, 2020
    Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Weihua Shi, Feng Xu, Zheng Wang, Weidong Li, Linghui Wu, Hongwei Li, Minggao Zeng, Kunmin Lai, Zhigan Jiang, Haiying He
  • Publication number: 20200231597
    Abstract: A bicyclic compound acting as a ROR? inhibitor. Provided are a compound of formula (I) or a pharmaceutically acceptable salt thereof, the compound having a structure as represented by formula (I-A) or formula (I-B). The provided compound of formula (I-A) or formula (I-B) or pharmaceutically acceptable salt thereof has good ROR? inhibitory activities, being expected to be used for treating diseases mediated by ROR? receptors in a mammal.
    Type: Application
    Filed: July 27, 2018
    Publication date: July 23, 2020
    Applicants: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD., MEDSHINE DISCOVERY INC.
    Inventors: Kevin X CHEN, Kai ZHOU, Yanxin YU, Boyu HU, Linghui WU, Xiaoyuan CHEN, Jiangfeng LIN, Haomin CHEN, Xiangjian WANG, Xiquan ZHANG, Xin TIAN, Hongjiang XU
  • Publication number: 20200223802
    Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.
    Type: Application
    Filed: March 20, 2020
    Publication date: July 16, 2020
    Applicant: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Weihua SHI, Feng XU, Zheng WANG, Weidong LI, Linghui WU, Hongwei LI, Minggao ZENG, Kunmin LAI, Zhigan JIANG, Haiying HE
  • Publication number: 20200131184
    Abstract: Provided are a compound represented by formula (I), an isomer or a pharmaceutically acceptable salt thereof, and an application of the same in preparing a drug for treating a disease related to A2A receptor. The R1, R2, R3, ring A, ring B, n, and m are as defined in the specification.
    Type: Application
    Filed: April 6, 2018
    Publication date: April 30, 2020
    Applicant: MEDSHINE DISCOVERY INC.
    Inventors: KEVIN X CHEN, Yanxin YU, Xinde CHEN, Li ZHANG, Zhaoguo CHEN, Cheng XIE, Xiaofei WANG, Linghui WU, Guoping HU, Jian LI, Shuhui CHEN
  • Patent number: 10633347
    Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: April 28, 2020
    Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Weihua Shi, Feng Xu, Zheng Wang, Weidong Li, Linghui Wu, Hongwei Li, Minggao Zeng, Kunmin Lai, Zhigan Jiang, Haiying He
  • Publication number: 20200024421
    Abstract: Curable liquid nano-composites for additive manufacturing of objects having precisely controlled mechanical and electronic properties are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure. The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include various opto-electronic devices such as conductive coatings, electro-chromic devices, electronic interconnects, antennae, RFID tags, transistors, diodes, photovoltaics, light emitting diodes, and capacitors.
    Type: Application
    Filed: September 26, 2019
    Publication date: January 23, 2020
    Inventors: Daniel SLEP, Linghui WU
  • Patent number: 10428196
    Abstract: Curable liquid nano-composites for additive manufacturing of objects having precisely controlled mechanical and electronic properties are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure. The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include various opto-electronic devices such as conductive coatings, electrochromic devices, electronic interconnects, antennae, RFID tags, transistors, diodes, photovoltaics, light emitting diodes, and capacitors.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: October 1, 2019
    Assignee: Schmutz IP, LLC
    Inventors: Daniel Slep, Linghui Wu
  • Publication number: 20190218189
    Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.
    Type: Application
    Filed: January 8, 2019
    Publication date: July 18, 2019
    Applicant: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Weihua SHI, Feng XU, Zheng WANG, Weidong LI, Linghui WU, Hongwei LI, Minggao ZENG, Kunmin LAI, Zhigan JIANG, Haiying HE
  • Patent number: 10227309
    Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: March 12, 2019
    Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Weihua Shi, Feng Xu, Zheng Wang, Weidong Li, Linghui Wu, Hongwei Li, Minggao Zeng, Kunmin Lai, Zhigan Jiang, Haiying He
  • Publication number: 20180141915
    Abstract: Disclosed are a method for preparing an imidazole derivative and crystal form A and crystal form B thereof, and also disclosed is a method for preparing a compound of formula (I) and an intermediate thereof.
    Type: Application
    Filed: June 7, 2016
    Publication date: May 24, 2018
    Applicant: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
    Inventors: Weihua SHI, Feng XU, Zheng WANG, Weidong LI, Linghui WU, Hongwei LI, Minggao ZENG, Kunmin LAI, Zhigan JIANG, Haiying HE
  • Publication number: 20180030235
    Abstract: Curable liquid nano-composites for additive manufacturing of objects having precisely controlled mechanical and electronic properties are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure. The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include various opto-electronic devices such as conductive coatings, electrochromic devices, electronic interconnects, antennae, RFID tags, transistors, diodes, photovoltaics, light emitting diodes, and capacitors.
    Type: Application
    Filed: December 10, 2015
    Publication date: February 1, 2018
    Inventors: Daniel SLEP, Linghui WU
  • Publication number: 20170368742
    Abstract: Curable liquid nano-composites for additive manufacturing of lenses are provided. Methods of making the curable nano-composites, and methods of additive manufacturing using the nano-composites are also provided. Additionally, objects made from additive manufacturing using the curable nano-composites are provided. In one or more embodiments, the nano-composites can contain one or more cross-linkable monomers or oligomers; a photo-initiator; and a nanoparticle. In some embodiments the curable liquid nano-composite can have a viscosity prior to curing of about 1-150 cP at room temperature and pressure The curable nano-composite can be used for additive manufacturing by printing the curable nano-composite. The printed objects can include optical lenses such as both prescription and non-prescription ophthalmic lenses.
    Type: Application
    Filed: December 10, 2015
    Publication date: December 28, 2017
    Inventors: Daniel SLEP, Linghui WU
  • Patent number: 9741602
    Abstract: A semiconductor device is disclosed that comprises a first non-volatile memory cell, a second non-volatile memory cell, an active region between the first and second memory cells, and an electrically conductive contact touching the active region, wherein the contact has a horizontal cross-section that is at least five percent smaller in a first dimension than in a second dimension.
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: August 22, 2017
    Assignee: NXP USA, INC.
    Inventors: Gong Chen, Linghui Wu
  • Publication number: 20130062773
    Abstract: A semiconductor device is disclosed that comprises a first non-volatile memory cell, a second non-volatile memory cell, an active region between the first and second memory cells, and an electrically conductive contact touching the active region, wherein the contact has a horizontal cross-section that is at least five percent smaller in a first dimension than in a second dimension.
    Type: Application
    Filed: September 8, 2011
    Publication date: March 14, 2013
    Inventors: GONG CHEN, LINGHUI WU
  • Patent number: D1077784
    Type: Grant
    Filed: November 27, 2023
    Date of Patent: June 3, 2025
    Assignee: XINADDA (HONG KONG) LIMITED
    Inventors: Hao Xu, Linghui Wu